Advertisements

Gets-It Corn/Callus Remover

Quick links to important sections

Gets-It Corn/Callus Remover

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Gets-It Corn/Callus Remover

Property Description
Active ingredient Salicylic Acid (INN) or Sodium Salicylate
Form Topical Solution (Liquid)
Pharmacological class Keratolytic Agent
Common use Non-surgical removal of corns and calluses
Origin Synthetic derivative

What Type of Medicine is Gets-It Corn/Callus Remover?

Gets-It Corn/Callus Remover is an established Over-The-Counter (OTC) topical preparation with a long history of use for skin management. Its pharmacological identity is defined as a Keratolytic Agent, a class of medicine specifically designed for cutaneous application to chemically soften and facilitate the removal of hardened, excess skin tissue.

The primary therapeutic purpose of the product is the management of hyperkeratosis, the skin thickening characteristic of corns and calluses. Salicylic Acid is an agent used to treat these common dermatological concerns. The medication is clinically recognized for targeting the dissolution and removal of abnormal skin formations caused by chronic pressure or friction.

Composition and Formulation: Salicylic Acid and Its Form

The core efficacy of this preparation is centered on its active substance, Salicylic Acid (INN), which is classified as a synthetic derivative belonging to the salicylate chemical group. The specific formulation of Gets-It is typically a Topical Solution (liquid), a distinguishing feature often utilizing a specialized, volatile vehicle, such as an alcohol-based or collodion mixture.

The liquid form's benefit is its capability for localized, precise application. This formulation ensures the active ingredient is delivered in a high concentration exactly to the surface of the corn or callus. Salicylic Acid achieves its therapeutic effect by breaking down the keratin structures within the targeted formulation.

How Does This Keratolytic Agent Generally Help?

This keratolytic agent generally helps by initiating a chemical process that causes the outermost skin cells of the hardened tissue to shed. Salicylic Acid works by dissolving the intercellular cement substance that binds the excess, dead skin cells together, while also increasing moisture content to soften the rigid protein keratin.

The outcome of this focused chemical softening is desquamation—the gradual, controlled peeling away of the thickened skin layer. By gently breaking the structural integrity of the skin buildup, the medicine works to provide relief by alleviating the intense pressure and friction points that corns and calluses often exert. This makes it a preferred non-abrasive method for at-home skin management.

Regulatory References

  1. Salicylic Acid Topical: MedlinePlus Drug Information
Advertisements

What side effects are possible with Gets-It Corn/Callus Remover?

Possible side effects and safety information

The official safety profile for topical Salicylic Acid, the active ingredient in this keratolytic preparation, is dominated by localized effects at the application site. Regulatory documents classify the medicine's risks based on frequency, system involvement, and specific constraints to prevent severe reactions.


Documented Adverse Reactions and Frequency

Adverse reactions are primarily associated with the Skin and Subcutaneous Tissue Disorders system-organ class. Reactions defined as Common or Frequent in regulatory materials are expected and are a consequence of the keratolytic action required to soften and remove hardened skin. These include application site reactions such as local irritation, burning sensation, erythema (redness), dryness, and peeling (desquamation).

Serious Adverse Reactions and Safety Constraints

The regulatory profile documents the potential for rare but serious adverse reactions, notably Systemic Salicylate Toxicity (Salicylism). Symptoms of Salicylism, such as tinnitus (ringing in the ears), dizziness, and hearing impairment, arise from excessive systemic absorption. Severe local damage, including ulceration or necrosis, is also documented, typically associated with prolonged use or improper application.

To mitigate these risks, official labeling establishes strict Safety-Related Restrictions. The product is contraindicated for use on the face, eyes, mucous membranes, moles, birthmarks, or broken/open skin. Furthermore, use is constrained for individuals with diabetes mellitus or poor blood circulation due to the higher risk of non-healing localized tissue damage.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose with topical salicylic acid products can lead to systemic salicylate toxicity (salicylism) if excessive amounts are absorbed, particularly if applied over large or damaged skin areas. Documented overdose presentations often affect the physiological systems, including the Central Nervous System and Gastrointestinal Tract, manifesting as tinnitus (ringing in the ears), nausea, vomiting, dizziness, headache, and hyperventilation. More severe or life-threatening manifestations described in regulatory documents include severe metabolic acidosis, seizures, coma, cardiovascular collapse, and respiratory failure.


When Immediate Medical Help is Required

The regulatory profile mandates that treatment must be stopped immediately upon any suspicion of systemic effects. Urgent medical care is required for any manifestation of overdose; patients should seek immediate medical attention or contact a Poison Control Center. Management involves symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known. This includes correcting severe fluid and electrolyte imbalances and close monitoring of plasma salicylate concentration. Population-specific notes confirm that children and individuals with compromised renal or hepatic function are at an increased risk of systemic accumulation and toxicity.

Advertisements

Therapeutic Uses of Gets-It Corn/Callus Remover

What Gets-It Corn/Callus Remover Treats: Main Uses and Benefits

The preparation is commonly used across therapeutic domains where short-term symptomatic assistance is needed for skin thickening. Topical Salicylic Acid is applied in conditions presenting with significant discomfort related to scaly or overgrown skin cells. The medication is relevant for managing two main conditions: corns and calluses, which are conditions presenting with rigid, dense skin patches.

Symptom Management and Functional Support

The primary therapeutic purpose is to contribute to improved comfort during symptomatic periods. The medicine supports the softening and controlled shedding of the rigid tissue, which may assist with managing the intense pressure and localized tenderness experienced when walking or standing. This action provides supportive symptomatic relief, contributing to easing the overall symptom load during periods of heightened discomfort. The product supports the management of these symptoms through chemical exfoliation, offering a manageable approach to addressing the thickened layer at home.

“This application assists patients with maintaining functional stability and supports general well-being during episodes of heightened discomfort.”

The softening process supports improved day-to-day comfort by addressing the physical strain of the hardened tissue, assists with maintaining functional stability, and supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Pressure and Friction Pain The product is commonly used in clinical scenarios where patients experience symptoms that interfere with daily functioning, and is applied in contexts where supportive self-management is sought.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed (as stated in label): Adults and Children 2 years of age and older are allowed use for the labeled indication (corns and calluses) under standard conditions.
Populations for whom use is not recommended (if applicable): Children younger than 2 years of age are not recommended for use.
Populations for whom use is contraindicated: Patients with diabetes or poor blood circulation (Absolute Contraindication).
Age-related eligibility rules: Special caution is required for teenagers and children who have influenza (flu) or varicella (chickenpox), as use must be avoided due to the risk of Reye's syndrome.
Condition-specific eligibility rules: Must not be used on skin that is irritated, infected, or reddened.
Pregnancy and lactation eligibility status (if explicitly documented): Pregnant or breastfeeding mothers should use with caution, with a specific restriction for nursing mothers not to apply the product to the chest area.
Eligibility-related restrictions: Must not be used on moles, birthmarks, or warts with hair growing from them, or on warts on the face, genitals, or mucous membranes.

Resulting Eligibility Structure

Official eligibility statements:

  • The medicine is contraindicated in patients with diabetes or poor blood circulation as mandated by regulatory labeling.
  • The product must not be used on irritated skin, or any area that is infected or reddened.
  • Use is not recommended in children younger than 2 years of age.
  • Children and teenagers with influenza or chickenpox must not use this product due to the risk of Reye's syndrome.

Connection to the overall eligibility profile: Official regulatory documents define strict non-eligibility based on pre-existing vascular/metabolic conditions (diabetes, poor circulation) and the local condition of the skin. Eligibility is further restricted by age, with use prohibited for infants and conditionally prohibited for children/teenagers recovering from certain viral illnesses.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Property Description
Medicinal product categories with documented interactions: Other topical peeling agents (e.g., resorcinol, benzoyl peroxide), systemic salicylate medicines (e.g., oral aspirin), other topical medicines, alcohol-containing preparations, and certain herbal products (e.g., containing methyl salicylate).
Specific interacting medicines (if explicitly listed): Oral aspirin (as a systemic salicylate).
Mechanistic basis of interactions (only if stated in label): Additive systemic salicylate exposure and Altered percutaneous absorption (may increase the absorption of other co-administered topicals).
Timing-based interaction rules (if applicable): Concomitant use with other topical medicines on the same treatment area must be avoided.
Population-specific interaction notes (if applicable): Risk of salicylate toxicity is heightened in populations with liver disease or kidney disease.
Interaction-related restrictions: Restricted from co-administration with other topical medicines on the same area and with oral or systemic salicylates. Restricted from use under occlusive dressings, on large areas, or for prolonged periods due to exposure risk.

Interaction classifications (high-level)

Classification Description
Interaction severity classification (as defined in official documents): Classified as Prohibited/Contraindicated use in specific conditions/populations and subject to Mandatory Avoidance/Restriction for co-administration with other topicals and systemic salicylates.
Regulatory basis (EMA / FDA / etc.): FDA Prescribing Information/DailyMed and official national regulatory warnings.
Interaction-context constraints (as defined in official documents): Interactions are contingent on the systemic exposure (application area size/duration) or local application site (co-administration on the same area).

Resulting interaction structure

Official regulatory documents define the product’s interaction structure primarily through avoidance rules concerning two exposure pathways: local additive effects that restrict the use of other topical irritants on the same skin area, and systemic exposure concerns that restrict co-administration with other salicylate-containing drugs. Use is officially prohibited in children and teenagers with varicella (chicken pox) or influenza (flu) due to the specific, severe outcome of Reye's syndrome. The structure also mandates caution in populations with impaired clearance, such as those with kidney or liver disease.

Advertisements

Mechanism of Action

The mechanism of action is defined by the chemical-physical alteration of the outer skin structure, focusing on dissolving the abnormally rigid buildup rather than altering systemic physiological processes.

Chemical Disruption of Corneocyte Adhesion

This domain covers the primary molecular target of Salicylic Acid: the corneodesmosomes. The acid initiates a process of desmolysis by lowering the local pH to denature and dissolve these structural proteins that link the dead skin cells (corneocytes) together. This targeted chemical action results in reduced adhesive strength within the hyperkeratotic tissue.

Desmolytic Cascade Leading to Tissue Shedding

The mechanistic cascade translates the dissolution of cellular bonds into a physiological effect. Loss of cohesion between corneocytes accelerates and enhances the natural process of desquamation (shedding). This results in controlled separation and facilitated shedding of the hyperkeratotic mass.

Non-Specific Localized Action Constraint

This domain highlights the constraint inherent in the mechanism. The desmolytic action is non-discriminatory and restricted to the stratum corneum at the application site. This localized chemical-physical constraint means that the non-discriminatory action requires the effect to be strictly localized to the target area.

Advertisements

Dosage and Administration Information

The administration of Gets-It Corn/Callus Remover, which contains Salicylic Acid, is strictly confined to the topical route. The medicine is provided as a topical solution (liquid) generally containing Salicylic Acid at a concentration ranging from 12% up to 27%, depending on the specific product formulation.

Administration Protocol

The usage protocol involves specific preparation of the application area. The corn or callus must first be washed and dried thoroughly, and preparation may include soaking the area in warm water for five minutes prior to application to assist with the process.

The dosing regimen is based on application rather than fixed volume. The standard application involves placing one drop of the liquid, or sufficient quantity to ensure the entire lesion is covered, directly onto the skin thickening. This procedure is repeated once or twice daily as part of the defined course of treatment.

Duration and Use Constraints

The course of treatment is intended to be short-term and goal-oriented. The daily application is continued for up to 14 days, or until the corn or callus is successfully removed through chemical exfoliation.

Standard protocol involves avoiding applying the solution to the surrounding, healthy skin to prevent localized tissue effects. After the application is complete, the solution must be allowed to dry completely. Furthermore, the product is not recommended for use in children younger than 2 years of age.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gets-It Corn/Callus Remover


Research Supporting Use in Corns and Calluses

This section summarizes the core clinical evidence base, including the types of controlled studies and authoritative regulatory assessments, that is consistent with the ingredient's recognition for the non-surgical subject of study of hardened skin tissue.

The active ingredient, topical Salicylic Acid, was studied for its use in managing corns and calluses, which are conditions characterized by hardened, thickened skin. These studies included controlled environments such as Randomized Controlled Trials (RCTs). Research has explored whether this treatment, when observed in studies of corns and calluses, impacted outcomes related to physical discomfort and the physical appearance of the lesions. Some trials also examined the treatment in studies where scalpel debridement was used as a comparator. The ingredient was the subject of regulatory review for these conditions, which reflects the overall consensus of the available research.


What Outcomes Were Measured in Clinical Trials?

Research explored patient-reported outcomes related to physical discomfort that corns and calluses often cause. Specifically, studies monitored how people reported their experience with localized pressure and pain. These patient-reported outcomes describing perceived discomfort were measured during the study period to observe if patterns related to symptom change emerged.

In addition to symptom reports, research examined the physical evolution of the skin condition itself. Findings describe patterns observed in the studies related to the physical status of the thickened skin, specifically tracking the status of the lesion at the final follow-up of the corn or callus. Studies monitored the progress of tissue shedding and reported how the lesions evolved in the observed populations over defined time intervals.


Long-Term Research and Durability of Observed Changes

Studies exploring short-term symptom changes typically followed participants for approximately three months. However, some clinical research explored the longer-term course of the condition, with certain trials monitoring patient responses for up to 12 months to gather data on the potential for the corns or calluses to return. While data show patterns related to how the lesions cleared, long-term effects are not fully established across the entire body of research. The evidence contributes to understanding symptom patterns, but there is limited information for long-term outcomes regarding how often and how quickly the condition recurs following the end of the treatment period for all observed populations.

Key Studies & References Topical treatments for corns and calluses: A systematic review and meta-analysis of randomized controlled trials

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Gets-It Corn/Callus Remover (FAQ)


Q: Is Gets-It Corn/Callus Remover the same as a wart remover?

Official information indicates that the active ingredient in Gets-It, salicylic acid, is used in topical medicines for both warts and corns/calluses. However, each specific product may have regulatory approval or be labeled for use only on corns and calluses. It is important to check the product's official labeling to understand its specific intended use.


Q: How quickly does Gets-It Corn/Callus Remover usually start to work?

Research-related information for the active ingredient suggests that clinically visible improvement normally begins within the first or second week of treatment. Information suggests that the process of resolution may take several weeks, which can vary depending on the size and severity of the skin thickening.


Q: Are there any known drug interactions to be aware of?

Official documents define avoidance rules, restricting co-administration with other topical medicines on the same treatment area. It is also advised to be cautious about concurrent use with other systemic salicylate-containing medicines, such as oral aspirin, due to the risk of increased salicylate exposure.


Q: What if I accidentally apply Gets-It Corn/Callus Remover to healthy skin?

Regulatory guidelines mandate avoiding application to surrounding healthy skin because the chemical action is non-discriminatory. Applying the solution to healthy skin may lead to localized adverse reactions, such as irritation, a burning sensation, or redness (erythema).


Q: What should I do if the treated area becomes red or irritated?

Local irritation and redness (erythema) are classified as common side effects associated with the active ingredient. Regulatory documents indicate that professional medical guidance is necessary if discomfort worsens during treatment or if serious adverse reactions, such as spreading redness or the formation of a deep sore (ulcer), are observed.


Q: Is Gets-It Corn/Callus Remover safe for use on people with fragile skin?

Regulatory guidance contraindicates use for people with pre-existing conditions like poor blood circulation or diabetes, and use is advised against on any skin that is already irritated, infected, or reddened. These restrictions reflect a potential risk of non-healing local tissue damage for populations with compromised or fragile skin.


Q: Can I use a pumice stone while treating the area with Gets-It?

Official usage instructions often mention that, after soaking the corn or callus in warm water and drying it thoroughly, it is acceptable to use a washcloth, emery board, or pumice stone to gently remove any loose tissue. These methods are often permitted in official usage instructions for the purpose of removing loose, treated tissue after soaking.


Q: Is it normal to feel a tingling sensation after applying the product?

While regulatory side effect lists explicitly document a burning or stinging sensation as a common, temporary effect, the specific sensation of tingling is not always explicitly documented. This type of feeling is consistent with the product's documented profile of localized irritation upon application.


Q: Is this product suitable for use on the hands?

The product is generally indicated for corns and calluses, which can occur on both the feet and hands. However, official warnings note the potential for severe redness or ulceration when using the product, which is a consideration regardless of the application site.


Q: How does the medicine know to only treat the corn or callus?

The mechanism of action is described as a non-discriminatory chemical action that is strictly localized to the outermost layer of the skin, the stratum corneum. It is the physical application of the product directly to the thickened tissue that targets the corn or callus, which is why official guidelines mandate avoiding healthy skin.


Q: Is Gets-It different from other salicylic acid corn removers?

Regulatory documents indicate that the main differences are typically in the specific concentration of the salicylic acid, which can range from 12% up to 27%. Variations are also found in the specific formulation (e.g., solution versus pad) and the vehicle used, which affects how the ingredient is delivered to the skin.


Q: Are there any known interactions between Gets-It and moisturizing creams?

Official documents state that co-administration with other topical medicines on the same treatment area must be avoided. Topical salicylic acid may also increase the absorption of other topically applied products, which could potentially include moisturizing creams.


Q: Do I need to cover the treated area after applying Gets-It?

Official application guidelines mandate that the solution must be allowed to dry completely after it is placed on the corn or callus. Separately, the product is restricted from use under occlusive dressings (air-tight coverings) due to the potential risk of increased systemic exposure.


Q: Does the product have an odor I should expect?

Regulatory information classifies the medicine as a Topical Solution (liquid) that is flammable and contains a specialized volatile vehicle. Due to the presence of these volatile components, a noticeable odor may be expected, and users are explicitly advised to avoid breathing in the vapors.


Q: Can I use nail polish or other foot products while using Gets-It?

Official warnings generally advise against using the product with any other topical preparation on the same affected area, which includes products like abrasive soaps or alcohol-containing cleansers. This is due to the potential for causing additive irritation or altered absorption of the medicine.


Q: What is the consistency of the product when it is applied?

The product is formulated as a Topical Solution (liquid) that often uses a specialized volatile vehicle, such as a collodion mixture. This formulation typically results in a liquid that is designed to dry and form a film over the treatment site upon application.


Q: Why is the product specifically labeled for corns and calluses?

The product is specifically labeled for corns and calluses because authoritative medical sources categorize the active ingredient as a Keratolytic Agent that is clinically recognized for managing the hyperkeratosis (skin thickening) characteristic of these conditions. This is the product's defined therapeutic purpose.


Q: Has any research examined the long-term effects of using this medicine?

Clinical trials often follow participants for approximately three months, and some research has monitored for up to 12 months to track recurrence. However, the available evidence indicates that the overall long-term effects are not fully established across the entire body of research.


Q: What is the role of the ingredients other than the active one?

The active ingredient's formulation utilizes a specialized volatile vehicle and other components. These non-active ingredients function to ensure the drug is delivered in a high concentration, allowing for a localized and precise application that dries quickly and forms a film over the lesion.


Q: Do I need a patch test before using the product for the first time?

Official guidance has included the use of a patch test by applying a small amount of the solution to an unaffected area of the skin. This can help identify potential allergic reactions before the product is used more extensively on the corn or callus.


Q: What is the difference between a corn and a callus in the context of this product?

Regulatory documents classify both corns and calluses as conditions of hyperkeratosis (abnormal skin thickening) that the product's active ingredient is designed to treat. The medicine acts as a Keratolytic Agent to dissolve the hardened tissue in both cases, focusing on the thickening itself rather than the lesion type.


Q: Is sun exposure a concern while using Gets-It?

Regulatory-related information advises that the use of topical salicylic acid can make the skin more sensitive to the sun (an effect called photosensitivity). This may lead to an increased risk of sunburn or other sun damage to the treated skin area.


Q: Can I go swimming after applying the medicine?

Official usage mandates that the solution must be allowed to dry completely after application. While swimming after the solution has dried is not explicitly forbidden, use in the presence of water is generally confined to soaking the area prior to application.


Q: Are there any materials or fabrics that the product might stain?

Official warnings note that the liquid is flammable. Furthermore, regulatory information advises that fabric (such as clothing or dressings) that has been in contact with the product can ignite more easily and should be considered a fire hazard.


Q: How is this product classified by health regulators?

The product is classified by health regulators as an Over-The-Counter (OTC) topical preparation. It belongs to the pharmacological class known as Keratolytic Agents, which are medicines designed to soften and remove hardened skin tissue.


Q: What should I do if I swallow Gets-It Corn/Callus Remover by accident?

Official safety guidelines state that the medicine may be harmful if swallowed. Official safety guidelines state that contacting a Poison Control Center or emergency room is necessary in case of accidental ingestion or overdose.


Q: Are there any warnings for people with allergies?

Official warnings document the potential for allergic reactions to the active ingredient or inactive components. In rare cases, serious symptoms such as swelling of the face, lips, or throat and trouble breathing have been documented.


Q: What is the expected appearance of the corn/callus as it is being treated?

The active ingredient works to cause desquamation, which is the peeling and controlled separation of the thickened skin. It is common for the treated area to display temporary effects like dryness and a white appearance due to this process of softening and shedding.


Q: Does the product have an expiration date I should look for?

While specific expiration dates are product-dependent, official guidelines advise that the product be stored at a controlled room temperature and has a defined shelf life. Official guidelines indicate that following the expiry dates printed on the product labeling is an aspect of proper handling.


Q: What are the official guidelines regarding product stability?

Official storage instructions mandate that the product be kept at controlled room temperature (e.g., 20 C to 25 C), sealed in a tightly closed container, and strictly kept away from fire and flame due to its flammable classification.


Q: Does Gets-It interact with any topical antibiotics?

Official interaction rules mandate avoiding concomitant use with other topical medicines on the same treatment area. This restriction applies to products like topical antibiotics and is enforced due to the risk of additive local irritation or altered absorption of either medicine.


Q: Can this remover cause discoloration of the skin?

The most common local reaction is temporary erythema (redness) and irritation. Permanent skin discoloration (hyperpigmentation) is not typically listed as a common effect in core regulatory documents, but it is a documented outcome associated with prolonged or severe localized inflammation.

Advertisements

How should Gets-It Corn/Callus Remover be stored and disposed of?

How to Store and Dispose of Gets-It Corn/Callus Remover

Storage and disposal of Gets-It Corn/Callus Remover must comply with official regulatory labeling to ensure product integrity and safety.

Required Storage and Safety Conditions

The product must be stored at controlled room temperature, typically maintained between 20 C and 25 C (68 F and 77 F). The liquid is classified as flammable and must be strictly kept away from fire and flame.

To prevent access, it is a mandatory requirement to store the container tightly closed and out of the reach and sight of children.

Official Disposal Instructions

Unused or expired medicine and its container must be managed according to local regulations for household hazardous waste. Due to the chemical and flammable components, it is officially restricted and must not be flushed down the toilet or poured into a household drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gets-It Corn/Callus Remover found in:

A-Z Index: